Zimmer Biomet Holdings Other Non-Current Liabilities increased by 0.7% to $630.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 30.6%, from $908.90M to $630.70M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -0.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $604.50M | $606.70M | $548.50M | $552.50M | $575.30M | $608.70M | $632.60M | $637.40M | $642.00M | $631.90M | $925.80M | $577.00M | $1.21B | $1.03B | $744.10M | $908.90M | $878.80M | $806.40M | $626.10M | $630.70M |
| QoQ Change | — | +0.4% | -9.6% | +0.7% | +4.1% | +5.8% | +3.9% | +0.8% | +0.7% | -1.6% | +46.5% | -37.7% | +108.9% | -14.7% | -27.6% | +22.1% | -3.3% | -8.2% | -22.4% | +0.7% |
| YoY Change | — | — | — | — | -4.8% | +0.3% | +15.3% | +15.4% | +11.6% | +3.8% | +46.3% | -9.5% | +87.8% | +62.7% | -19.6% | +57.5% | -27.1% | -21.6% | -15.9% | -30.6% |